Home Cart 0 Sign in  
X

[ CAS No. 144072-29-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 144072-29-7
Chemical Structure| 144072-29-7
Chemical Structure| 144072-29-7
Structure of 144072-29-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 144072-29-7 ]

Related Doc. of [ 144072-29-7 ]

Alternatived Products of [ 144072-29-7 ]

Product Details of [ 144072-29-7 ]

CAS No. :144072-29-7 MDL No. :MFCD04974271
Formula : C12H17NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :YQKDTZYYROHLMB-UHFFFAOYSA-N
M.W : 223.27 Pubchem ID :10242688
Synonyms :

Calculated chemistry of [ 144072-29-7 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.42
Num. rotatable bonds : 5
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 62.82
TPSA : 58.56 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.53 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.4
Log Po/w (XLOGP3) : 1.6
Log Po/w (WLOGP) : 2.18
Log Po/w (MLOGP) : 1.8
Log Po/w (SILICOS-IT) : 1.57
Consensus Log Po/w : 1.91

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.18
Solubility : 1.48 mg/ml ; 0.00661 mol/l
Class : Soluble
Log S (Ali) : -2.44
Solubility : 0.808 mg/ml ; 0.00362 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.19
Solubility : 0.145 mg/ml ; 0.000652 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.95

Safety of [ 144072-29-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 144072-29-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 144072-29-7 ]
  • Downstream synthetic route of [ 144072-29-7 ]

[ 144072-29-7 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 144072-29-7 ]
  • [ 66493-39-8 ]
Reference: [1] RSC Advances, 2015, vol. 5, # 4, p. 2647 - 2654
  • 2
  • [ 24424-99-5 ]
  • [ 623-04-1 ]
  • [ 144072-29-7 ]
YieldReaction ConditionsOperation in experiment
100% With N-ethyl-N,N-diisopropylamine In tetrahydrofuranHeating / reflux To a solution of p-amino-benzylalcohol (1 g, 8.12 mmol, 1 eq) in 80 mL of anhydrous THF were added DIEA (1.4 mL, 8.12 mmol, 1 eq) and BoC2O (1.9 mL, 8.12 mmol, 1 eq). The mixture was heated to reflux overnight, then cooled down and evaporated under vacuum. The residue was dissolved in EtOAc. The organic layer was washed with a 0.1 N HCl solution, dried over MgSO4, filtered and evaporated under vacuum. The crude product was purified by <n="74"/>column chromatography on silica gel (Hex-EtOAc, 1:1, v/v) to give 1.85 g of product (quantitative yield): 1H NMR δ 0.1.49 (9H, s), 2.17 (IH, s), 4.53 (2H5 s), 6.83 (IH, s), 7.19 (2H, d, J = 8.5 Hz), 7.28 (2H, d, J = 8.2 Hz); 13 C NMR δ 28.28, 64.54, 80.37, 118.49, 127.59, 135.31, 137.46, 152.72.
98% for 18 h; To a 250 mL round bottom flask was added (4-amino-phenyl)-methanol (4.13 g, 33.6 mmol), dichloromethane (50 mL) followed by di-tert-butyl dicarbonate (8.5 g, 36.9 mmol). The mixture was allowed to stir for 18 h under a nitrogen atmosphere. By TLC, a small amount of starting amine remained, which reacted during concentration by rotary evaporation. The product was purified by column chromatography (ethyl acetate : hexanes, 1:1) to yield (4- hydroxymethyl-phenyl)-carbamic acid tert-butyl ester (7.36 g, 33.0 mmol, 98 percent) as a white solid.
98% at 80℃; for 0.166667 h; Green chemistry General procedure: The reactions were carried out in a 50 mL RB flask under reduced pressure for 10 min at 80°C unless reported differently. In a typical experiment, 5 mmol of amine was added to 5 mmol of BOC anhydride, and the reaction was allowed to proceed for 10 min. The desired product was obtained in a rotary evaporator under vacuum conditions.
87% With sodium hydroxide In 1,4-dioxane; water at 0 - 20℃; for 1.5 h; PREPARATION 15; Preparationof teri-buty\\ 4-(chloromethyl)phenylcarbamate; A. To a stirred solution of 4-aminobenzyl alcohol ( 1.50 g. 12.18 mmol) in 1.4-dioxane (30 mL) was added sodium hydroxide (0.49 g. 12.2 mmol) in water (30 mL). The mixture was cooled to 0 0C. and di-/1H NMR (300 MHz. CDCl3) δ 7.37-7.26 (m. 4H). 6.52 (br s. I H). 4.63 (s, 2H). 1.52 (s. 9H); MS (ES+) m/z 246.3 (M + 23).
83% With triethylamine In tetrahydrofuran at 20 - 50℃; A i00-mL, three-necked, round-bottomed flask, was equipped with a magnetic stimng bar, a retlux condenser, and a pressure-equalizing dropping funnel that was connected to a nitrogen flow line and charged with a solution of 97percent di-tert-butyl dicarbonate (4.04 g, 18.5 nimol) in tetralydrofuran (30 mid). Amino benzyi alcohol (2.5 g, 20.3 mmol) was placed in the flask and suspended in tetrahydrofuran (65 mL) and 99percent triethylamine (3.1 mL, 22 mmoi). The resultmg white suspension was cooled with an ice-water bath and the solution of di-tert-butyl dicarbonate was added dropwise over a period of 30 minutes. After 10 mm of additional stirring, the ice-water bath was removed and the suspension was stirred overnight at room temperature, then warmed at 50°C for a further 3 hours. T he solvent was removed tinder reduced pressure and the residue partitioned between EtOAc (50 mL) and saturated aqueous bicarbonate solution (50 mL). The aqueous phase was extracted with three 50-ni. portions of EtOAc. The combined organic phases were dried with anhydrous MgSO4 and concentrated under reduced pressure to give 3.72 g (83percent yield) of the product as a brown oil that was used without further purification. ‘H NMR (as rotamers) (400 MHz, CDCh) 6 9.26 (s, I H), 8.64 (s, iH), 7.39 (.4H), 7.20 (4H), 5,75 (s, 1H), 5.05 (2H), 4.49 —4.35 (m, 4H), i.47 (s, 9H), 1.40 (s, 1H).
82% With triethylamine In 1,4-dioxane at 20℃; Intermediate 10: tert-butyl 4-(hydroxymethyl)phenylcarbamateTo a solution of p-aminobenzyl alcohol (38,2 mmol) in 100 ml dioxane were added triethylamine (114 mmol) and di-tert-butyldicarbonate (42,0 mmol) was added in portions. The mixture was stirred overnight at room temperature. The solvent was evaporated. EtOAc was added and washed with 2N HCI, saturated NaHCO3 and brine solution. The organic layer was dried over Na2SO4 and evaporated to yield a brown oil.Yield: 82 percent, MS (ESI) m/z 224.3 [M+H]1H-NMR (ODd3, 400 MHz) 51.54 (s, 9H), 4.65 (s, 2H), 6.54 (s, 1H), 7.22-7.43 (m, 4H).
74% With acetic acid In tetrahydrofuran; water at 20℃; for 18 h; Inert atmosphere tert-Butyl (4-(hydroxymethyl)phenyl)carbamate 19. To a solution of ra-aminobenzyl alcohol (0.123 g, 0.0999 mmol) in AcOH (10percent in water, 8 mL) was added a solution of di-feri-butyl dicarbonate in THF (1 M, 1.05 mL, 1 .05 mmol), and the reaction was stirred for 18 h at ambient temperature. Water (30 mL) was added, and the mixture was basified with a NaOH solution (2 M) to pH 14. The resulting mixture was extracted with Et20 (3 χ 30 mL). The combined organic layer was washed with water (2 x 1 5 mL), dried over Na2S04, filtered, and concentrated under reduced pressure to afford boc-protected aminobenzyl alcohol 19 (0.166 g, 0.743 mmol, 74percent yield) as a light yellow solid. [000219] NMR (600 MHz, CDC13) δ 7.34 (2H, d, J = 8.0 Hz), 7.28 (2H, d, J = 8.4 Hz), 4.62 (2H, s), 1 .52 (9H, s). [000220] 13C NMR (150 MHz, CDC13) δ 152.9, 138.0, 135.6, 128.0, 1 18.7, 65.1 , 31.3, 28.5. [000221] HRMS: Obsvd 246.1 102 [M + Na]+, Calcd for C12H17NNa03: 246.1 101.
59% With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 20℃; To a solution of (4-aminophenyl)methanol (30, 8.0 g, 65.0 mmol) in THF (50 mL) were added Boc2O (21.3 g, 97.5 mmol) and DIEA (16.8 g, 130.0 mmol) at rt, and the resulting mixture was refluxed overnight. The reaction mixture was concentrated and purified by column chromatography (silica gel, eluted with 1:10 MeOH/DCM) to yield 31 (8.6 g, 59percent) as a yellow solid. 1H NMR (400 MHz, CD3OD) δ 1.53 (9H, s), 4.54 (2H, s), 7.26 (2H, d, J = 8.4 Hz), 7.38 (2H, d, J = 8.4 Hz). MS (API): m/z 206.0 (M + H - H2O)+.

Reference: [1] Patent: WO2008/34124, 2008, A2, . Location in patent: Page/Page column 72-73
[2] Patent: WO2006/31806, 2006, A2, . Location in patent: Page/Page column 99
[3] Research on Chemical Intermediates, 2017, vol. 43, # 3, p. 1355 - 1363
[4] Tetrahedron Letters, 2007, vol. 48, # 51, p. 9044 - 9047
[5] Journal of Medicinal Chemistry, 1992, vol. 35, # 22, p. 4150 - 4159
[6] Organic and Biomolecular Chemistry, 2006, vol. 4, # 7, p. 1305 - 1312
[7] Patent: WO2008/127349, 2008, A2, . Location in patent: Page/Page column 103
[8] Patent: WO2015/26990, 2015, A2, . Location in patent: Page/Page column 44; 45
[9] Patent: WO2015/144933, 2015, A1, . Location in patent: Page/Page column 33; 34
[10] Patent: WO2017/66668, 2017, A1, . Location in patent: Paragraph 000218-000221
[11] Tetrahedron Letters, 2010, vol. 51, # 33, p. 4371 - 4374
[12] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 12, p. 3018 - 3033
[13] Journal of Medicinal Chemistry, 2015, vol. 58, # 23, p. 9354 - 9370
[14] Journal of Medicinal Chemistry, 1989, vol. 32, # 4, p. 811 - 826
[15] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 24, p. 4293 - 4297
[16] Journal of Medicinal Chemistry, 2004, vol. 47, # 10, p. 2411 - 2413
[17] Patent: US2004/157900, 2004, A1, . Location in patent: Page 5
[18] Patent: US2003/153752, 2003, A1,
[19] Patent: US2003/153752, 2003, A1,
[20] Patent: US2004/77646, 2004, A1, . Location in patent: Page 93
[21] Chemistry of Materials, 2011, vol. 23, # 21, p. 4844 - 4856
[22] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 14, p. 3614 - 3622
  • 3
  • [ 144072-30-0 ]
  • [ 144072-29-7 ]
Reference: [1] ACS Catalysis, 2017, vol. 7, # 10, p. 7371 - 7377
  • 4
  • [ 34619-03-9 ]
  • [ 623-04-1 ]
  • [ 144072-29-7 ]
Reference: [1] Patent: EP2123637, 2009, A1, . Location in patent: Page/Page column 75
  • 5
  • [ 24424-99-5 ]
  • [ 150-13-0 ]
  • [ 144072-29-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 20, p. 5591 - 5593
  • 6
  • [ 24424-99-5 ]
  • [ 144072-29-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2001, vol. 44, # 26, p. 4737 - 4740
  • 7
  • [ 1239374-04-9 ]
  • [ 144072-29-7 ]
Reference: [1] European Journal of Organic Chemistry, 2010, # 19, p. 3704 - 3710
  • 8
  • [ 66493-39-8 ]
  • [ 144072-29-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 16, p. 4879 - 4883
  • 9
  • [ 144072-29-7 ]
  • [ 239074-27-2 ]
YieldReaction ConditionsOperation in experiment
57% With N-Bromosuccinimide; triphenylphosphine In dichloromethane at 0 - 20℃; for 1 h; To a 1 L round bottom flask was added (4-hydroxymethyl-phenyl)-carbamic acid tert-butyl ester (22.3 g, 0.10 mol) obtained from Examples 2pp through 2ooo, Step 1, dichloromethane (400 mL) and triphenylphospine (31.5 g, 0.12 mol). Upon cooling to 0 °C, N-bromosuccinimide (19.6 g, 0.11 mmol) was added in small portions and the reaction was allowed to warm to room temperature and stirred under nitrogen for 1 h. The mixture was transferred into a large flask and hexanes were added until the solution became turbid. The solution was eluted through a plug of silica (300 g) with 1:9 ethyl acetate :hexanes and concentrated to yield (4-bromomethyl-phenyl)-carbamic acid tert-butyl ester (12.8 g, 0.057 mol, 57 percent) as a white solid which was sufficiently pure by 1H NMR to proceed to the next step: 1H NMR (300 MHz5 CDCl3) δ 8.00 (s, IH), 7.52 (d, 2H), 7.04 (d, 2H), 4.56 (s, 2H), 1.40 (s, 9H).
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 23, p. 9354 - 9370
[2] Patent: WO2006/31806, 2006, A2, . Location in patent: Page/Page column 99
[3] Journal of Medicinal Chemistry, 1989, vol. 32, # 4, p. 811 - 826
  • 10
  • [ 144072-29-7 ]
  • [ 220298-96-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 16, p. 4879 - 4883
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 144072-29-7 ]

Aryls

Chemical Structure| 205318-52-1

[ 205318-52-1 ]

3-(Aminomethyl)-1-N-Boc-aniline

Similarity: 0.92

Chemical Structure| 104060-23-3

[ 104060-23-3 ]

N-Boc-2-(4-Aminophenyl)ethanol

Similarity: 0.90

Chemical Structure| 71026-66-9

[ 71026-66-9 ]

tert-Butyl (4-aminophenyl)carbamate

Similarity: 0.88

Chemical Structure| 111331-82-9

[ 111331-82-9 ]

Boc-3-aminobenzoic acid

Similarity: 0.88

Chemical Structure| 263403-72-1

[ 263403-72-1 ]

tert-Butyl 2-Boc-aminobenzylcarbamate

Similarity: 0.87

Alcohols

Chemical Structure| 104060-23-3

[ 104060-23-3 ]

N-Boc-2-(4-Aminophenyl)ethanol

Similarity: 0.90

Chemical Structure| 279255-90-2

[ 279255-90-2 ]

tert-Butyl 5-(hydroxymethyl)-1H-indole-1-carboxylate

Similarity: 0.86

Chemical Structure| 354587-72-7

[ 354587-72-7 ]

tert-Butyl 6-(hydroxymethyl)-1H-indole-1-carboxylate

Similarity: 0.86

Chemical Structure| 123986-64-1

[ 123986-64-1 ]

tert-Butyl 4-(hydroxymethyl)benzylcarbamate

Similarity: 0.80

Chemical Structure| 226070-69-5

[ 226070-69-5 ]

tert-Butyl 3-(hydroxymethyl)benzylcarbamate

Similarity: 0.80

Amides

Chemical Structure| 205318-52-1

[ 205318-52-1 ]

3-(Aminomethyl)-1-N-Boc-aniline

Similarity: 0.92

Chemical Structure| 104060-23-3

[ 104060-23-3 ]

N-Boc-2-(4-Aminophenyl)ethanol

Similarity: 0.90

Chemical Structure| 71026-66-9

[ 71026-66-9 ]

tert-Butyl (4-aminophenyl)carbamate

Similarity: 0.88

Chemical Structure| 111331-82-9

[ 111331-82-9 ]

Boc-3-aminobenzoic acid

Similarity: 0.88

Chemical Structure| 263403-72-1

[ 263403-72-1 ]

tert-Butyl 2-Boc-aminobenzylcarbamate

Similarity: 0.87

Amines

Chemical Structure| 205318-52-1

[ 205318-52-1 ]

3-(Aminomethyl)-1-N-Boc-aniline

Similarity: 0.92

Chemical Structure| 104060-23-3

[ 104060-23-3 ]

N-Boc-2-(4-Aminophenyl)ethanol

Similarity: 0.90

Chemical Structure| 71026-66-9

[ 71026-66-9 ]

tert-Butyl (4-aminophenyl)carbamate

Similarity: 0.88

Chemical Structure| 111331-82-9

[ 111331-82-9 ]

Boc-3-aminobenzoic acid

Similarity: 0.88

Chemical Structure| 263403-72-1

[ 263403-72-1 ]

tert-Butyl 2-Boc-aminobenzylcarbamate

Similarity: 0.87